Healthcare provider profile · identity verified

Daniel Olea-Mendoza, MD

Internal Medicine · CAMDEN, NJ · NPI 1083177414

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	715	193
Amlodipine Besylate	Amlodipine Besylate	514	145
Gabapentin	Gabapentin	347	98
Metformin Hcl	Metformin Hcl	328	92
Lisinopril	Lisinopril	318	95
Albuterol Sulfate Hfa	Albuterol Sulfate	294	84
Rosuvastatin Calcium	Rosuvastatin Calcium	289	87
Pantoprazole Sodium	Pantoprazole Sodium	268	81
Omeprazole	Omeprazole	202	54
Fluticasone Propionate	Fluticasone Propionate	193	69
Carvedilol	Carvedilol	173	53
Olmesartan Medoxomil	Olmesartan Medoxomil	169	41
Jardiance	Empagliflozin	160	39
Famotidine	Famotidine	145	42
Levothyroxine Sodium	Levothyroxine Sodium	132	42
Duloxetine Hcl	Duloxetine Hcl	129	31
Tamsulosin Hcl	Tamsulosin Hcl	129	42
Montelukast Sodium	Montelukast Sodium	122	29
Metoprolol Succinate	Metoprolol Succinate	120	40
Losartan Potassium	Losartan Potassium	115	42
Chlorthalidone	Chlorthalidone	108	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	108	28
Trazodone Hcl	Trazodone Hcl	107	25
Mirtazapine	Mirtazapine	105	28
Diclofenac Sodium	Diclofenac Sodium	94	49
Hydrochlorothiazide	Hydrochlorothiazide	84	33
Furosemide	Furosemide	80	25
Escitalopram Oxalate	Escitalopram Oxalate	78	21
Ozempic	Semaglutide	74	17
Ezetimibe	Ezetimibe	73	26
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	70	22
Farxiga	Dapagliflozin Propanediol	69	18
Sertraline Hcl	Sertraline Hcl	65	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	35
Torsemide	Torsemide	60	18
Alendronate Sodium	Alendronate Sodium	57	17
Metformin Hcl Er	Metformin Hcl	55	18
Trulicity	Dulaglutide	51	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Valsartan	Valsartan	49	15
Ventolin Hfa	Albuterol Sulfate	47	13
Eliquis	Apixaban	45	15
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Spironolactone	Spironolactone	45	14
Breo Ellipta	Fluticasone/Vilanterol	44	13
Alprazolam	Alprazolam	42	suppressed
Naproxen	Naproxen	41	25
Glipizide	Glipizide	40	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Ibuprofen	Ibuprofen	36	22
Januvia	Sitagliptin Phosphate	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	13
Humalog Kwikpen U-100	Insulin Lispro	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	12
Comfort Ez Pen Needle	Pen Needle, Diabetic	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	11
Entresto	Sacubitril/Valsartan	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	24	suppressed
Finasteride	Finasteride	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Meloxicam	Meloxicam	23	suppressed
Ondansetron Odt	Ondansetron	23	15
Simvastatin	Simvastatin	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Naloxone Hcl	Naloxone Hcl	22	14
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	21	17
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Olanzapine	Olanzapine	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	13
Potassium Chloride	Potassium Chloride	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Easy Comfort Pen Needles	Pen Needle, Diabetic	17	suppressed
Estradiol	Estradiol	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Victoza 2-Pak	Liraglutide	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Atenolol	Atenolol	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error